Jasper Therapeutics’ Post

📣 Please find the summary of our COVAC-CU -a GA²LEN e.V. UCARE and ACARE- Project which is published @JACI American Academy of Allergy, Asthma and Immunology - AAAAI with Marcus Maurer and many urticaria experts all over the world. 🔔 The message is: ''COVID-19 vaccines are safe in chronic urticaria patients, only minority shows disease exacerbations'' 🔎 Please click the link for a short summary and important points of the paper 👇 https://lnkd.in/dnqGh2DC

Another important milestone for #TBCPartner Intellia Therapeutics, Inc., who announced positive long-term data from its in vivo Phase 1 study of NTLA-2002 for hereditary angioedema (HAE). NTLA-2002 continues to show durable reduction of monthly attack rates with just a single dose, and potential to be a functional cure for people living with this rare disease. Fantastic progress for in vivo gene editing, the field of genomic medicine and #CRISPR technology!

Excellent video by Brian Kim explaining neuroimmune cross talk in various type two immune disorders!

We will be present at the 2024 European Academy of Allergy and Clinical Immunology - EAACI congress in Valencia (ESP) from 31 May to 3 June. You can meet us during the following sessions: FT 02 - Flash talks on Asthma (8.30-10.00, 31 May) Asthma response in patients with allergic rhinoconjunctivitis to grass pollen using an environmental exposure chamber. TPS27 - Prevention (12.00-13.00, 31 May) Evaluation of temperature-controlled laminar airflow technology to filter aeroallergen-contaminated ambient air in environmental exposure chamber. #EAACIcongress

What are inborn errors of immunity, what causes them, and how do we navigate the challenges in diagnosing them? If you’re interested in the intersection between rheumatology and allergy immunology, we’ve got Dr. Bharat Kumar with us to shed light on these questions and more. Don’t miss it, HERE → https://acr.tw/4ecUHY4

A unique chance to test your knowledge and skills in Allergy and Immunology field

📣 Tune in to hear our latest podcast on the most interesting research related to #eczema presented at the recent European Academy of Allergy and Clinical Immunology - EAACI annual meeting in Valencia, Spain, attended by our executive director, Korey Capozza! Topics include the impact of #microplastics on the body's immune system and the latest research on predicting #atopicdermatitis in children. https://lnkd.in/gbmc9M8w

Important progress has been gained in the journey towards understanding response to biologic therapy in severe asthma through the International Severe Asthma Registry (ISAR) study “Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma (BEAM)”, published in Annals of Allergy, Asthma, & Immunology and delivered in collaboration with respiratory experts and AstraZeneca. Read the full press release: https://lnkd.in/eUykgwHN Read the full article here: https://lnkd.in/eEajatUT #ResearchInRealLife #SevereAsthma #Asthma #Research

🌟 Exciting Announcement! 📢 Journal of Immunology and Allergy feels thrilled to share an insightful article titled "More Than a Classificatory and Diagnostic Marking, a Prognostic Importance of Antibodies in Autoimmune Liver Diseases." This article sheds light on the Autoimmune liver diseases. 🔗 Read the full article here: https://lnkd.in/dR6TVgFs This article gives insights into Autoimmune hepatitis (AIH) characterized by the presence of antibodies, polyclonal hypergammaglobulinemia, and periportal infiltration that are not due to another viral, medicated, or toxic cause. Let's delve deeper and engage in a broader conversation about the diagnosis of autoimmune hepato-cholangiopathies. Share your thoughts, insights, and experiences in the comments section below the article. #autoimmunediseases #infiltration #hepatitis #immunology #liver #hypergammaglobulinemia #antibodies

#medicalaffairs leaders, this episode is a must listen for your #msl team! You won’t regret it! Please be sure to share with your network! #mslvalueintheeyesoftheKOL